Technical considerations in the application of intensity-modulated radiotherapy as a concomitant integrated boost for locally-advanced cervix cancer

Medical Dosimetry

Volumn 27, Issue 2, 2002, Pages 177-184

  Schefter, Tracey E ^a   Kavanagh, Brian D ^a   Wu, Qiuwen ^b   Tong, Shidong ^b   Newman, Francis ^a   Mccourt, Steve ^a   Arnfield, Mark ^b   Benedict, Stanley ^b   Mohan, Radhe ^b  

^a UNIVERSITY OF COLORADO   (United States)

^b VIRGINIA COMMONWEALTH UNIVERSITY   (United States)

Author keywords

Carvix cancer; IMRT

Indexed keywords

ACCURACY; ARTICLE; BRACHYTHERAPY; CONTROLLED STUDY; HUMAN; PRIORITY JOURNAL; RADIATION DOSE DISTRIBUTION; THEORETICAL STUDY; TREATMENT PLANNING; UTERINE CERVIX CARCINOMA; COMPUTER ASSISTED RADIOTHERAPY; FEMALE; HOSPITALIZATION; MULTIMODALITY CANCER THERAPY; RADIATION DOSE; REVIEW; UTERINE CERVIX TUMOR;

BRACHYTHERAPY; CERVIX NEOPLASMS; COMBINED MODALITY THERAPY; FEMALE; HUMAN; RADIOTHERAPY DOSAGE; RADIOTHERAPY PLANNING, COMPUTER-ASSISTED; RADIOTHERAPY, CONFORMAL; SEVERITY OF ILLNESS INDEX; HUMANS; UTERINE CERVICAL NEOPLASMS;

EID: 0035987852     PISSN: 09583947     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0958-3947(02)00101-2     Document Type: Article

References (26)

1. The potential for sparing of parotids and escalation of biologically effective dose with intensity-modulated radiation treatments of head and neck cancers: A treatment design study
2. Xerostomia and its predictors following parotid-sparing irradiation of head and neck cancer
3. Towards multidimensional radiotherapy (MD-CRT): Biological imaging and biological conformality
4. A Radiation Therapy Oncology Group (RTOG) Phase III randomized study to compare hyperfractionation and two variants of accelerated fractionation to standard fractionation radiotherapy for head and neck squamous cell carcinomas: First report of RTOG 9003
5. A pilot study of concomitant boost accelerated superfractionated radiotherapy for stage III cancer of the uterine cervix
6. Clinical application of intensity-modulated radiotherapy for locally advanced cervical cancer
7. Concurrent cisplatin-based chemotherapy and radiotherapy for locally advanced cervical cancer
8. Tumor diameter and volume assessed by magnetic resonance imaging in the prediction of outcome for invasive cervical carcinoma
9. Intensity-modulated whole pelvis radiation therapy in patients with gynecologic malignancies
10. Impact of the filling of the bladder and the rectum on their integral dose distribution and the movement of the uterus in the treatment planning of gynecologic cancer
11. Ultrasound-based stereotactic guidance in prostate cancer - Quantification of organ motion and setup errors in external beam therapy
12. The reproducibility of organ position using active breathing control (ABC) during liver radiotherapy
13. Four-dimensional treatment planning and fluoroscopic real-time tumor tracking radiotherapy for moving tumor
14. Intensity modulated radiation therapy (IMRT): A new promising technology in radiation oncology
15. Computerassisted slection of beam energy and orientation in IMRT
16. Fast iterative algorithms for three-dimensional inverse treatment planning
17. Dosimetric verification of an intensity modulated treatment
18. Algorithms and functionality of an intensity modulated radiotherapy optimization system
19. Dynamic splitting of large intensity-modulated fields
20. Intensity-modulated radiation therapy (IMRT) reduces small bowel, rectum, and bladder doses in patients with cervical cancer receiving pelvic and para-aortic irradiation
21. Pelvic radiation with concurrent chemotherapy compared with pelvic and para-aortic radiation for high-risk cervical cancer
22. Concurrent cisplatin-based radiotherapy and chemotherapy for locally advanced cervical cancer
23. Long-term local control and survival following concomitant boost accelerated radiotherapy for locally advanced cervix cancer
24. Preliminary results of a randomized radiotherapy dose-escalation study comparing 70 Gy with 78 Gy for prostate cancer
25. High dose radiation therapy by intensity modulated radiotherapy improves the outcome of localized prostate cancer
26. Short-course intensity-modulated radiotherapy (70 Gy at 2.5 Gy per fraction) for localized prostate cancer: Preliminary results on late toxicity and quality of life